Company Concord Biotech Limited

CONCORDBIO

INE338H01029

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 02:29:22 08/07/2025 pm IST			5-day change	1st Jan Change
1,788.50 ^INR	+1.57%		-0.23%	-18.98%

08/07	Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025
02/07	Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited	CI

Business description: Concord Biotech Limited

Concord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic process and finished formulations. The Companyâs offerings span both bio-pharmaceutical APIs and formulations across therapeutic areas like immunosuppressants oncology, anti-infectives nephrology, and critical care. Its portfolio also includes fermentation-based APIs in anti-bacterial, anti-fungal, and other therapeutic segments. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Sirolimus, Pimecrolimus, Voclosporin, Mupirocin, Mupirocin Calcium, Vancomycin Hydrochloride, Teicoplanin, Polymyxin B Sulfate, Fidaxomicin, Anidulafungin. Its API products under development include Daptomycin, Epirubicin, Idarubicin, and Pirarubicin.

Number of employees: 1,377

Sales by Activity: Concord Biotech Limited

Fiscal Period: March	2020	2021	2022	2023	2024
Manufacturing and trading in pharmaceutical products	512.33Cr	616.4Cr	712.93Cr	853.17Cr	1.02TCr

See all business segments

Geographical breakdown of sales: Concord Biotech Limited

Fiscal Period: March	2020	2021	2022	2023	2024
India	261.56Cr	252.65Cr	337.41Cr	432.13Cr	534.21Cr
Others	170.96Cr	204.5Cr	244.07Cr	273.78Cr	374.75Cr
America	80Cr	159.25Cr	131.45Cr	147.25Cr	107.98Cr

See all geographic segments

Executive Committee: Concord Biotech Limited

Manager	Title	Age	Since
Sudhir Vaid CEO	Chief Executive Officer	72	10/05/2000
Ankur Sudhir Vaid CEO	Chief Executive Officer	-	01/09/2011
Lalit Sethi DFI	Director of Finance/CFO	59	14/03/2022
Subhash Nair PRN	Corporate Officer/Principal	-	10/04/2017
Manoj Kumar PRN	Corporate Officer/Principal	-	-

See CONCORD BIOTECH LIMITED governance

Composition of the Board of Directors: Concord Biotech Limited

Director	Title	Age	Since
Rajiv Ambrish Agarwal BRD	Director/Board Member	54	30/06/2008
Sudhir Vaid CHM	Chairman	72	10/05/2000
Ravi N. Kapoor BRD	Director/Board Member	62	15/12/2003
Amitabh Gajendra Thakore BRD	Director/Board Member	80	31/01/2017
Jayaram Easwaran BRD	Director/Board Member	72	14/06/2022
Bharti Khanna BRD	Director/Board Member	57	31/01/2017
Arvind Motilal Agarwal BRD	Director/Board Member	65	24/05/2022
Mandayam Chakravarthy Sriraman BRD	Director/Board Member	79	14/06/2022
Ankur Sudhir Vaid BRD	Director/Board Member	-	01/09/2011

Composition of the Board of Directors

Shareholders: Concord Biotech Limited

Name	Equities	%	Valuation
Sudhir Vaid 28.84 %	3,01,69,524	28.84 %	650 M ₹
Manju Vaid 9.547 %	99,87,384	9.547 %	215 M ₹
Aryavir Jhunjhunwala Discretionary Trust 8.029 %	83,99,754	8.029 %	181 M ₹
Aryaman Jhunjhunwala Discretionary Trust 8.029 %	83,99,754	8.029 %	181 M ₹
Nishtha Jhunjhunwala Discretionary Trust 8.029 %	83,99,732	8.029 %	181 M ₹

List of CONCORD BIOTECH LIMITED shareholders

Company details: Concord Biotech Limited

Concord Biotech Ltd.

B-Wing, Mondeal Heights Iscon Cross Road, S.G. Highway

380015, Ahmedabad

+91 79 6813 8700

http://www.concordbiotech.com

address Concord Biotech Limited(CONCORDBIO)

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
CONCORD BIOTECH LIMITED	+1.57%	-0.23%	+6.04%	-	214.76Cr
CSL LIMITED	-0.82%	+3.23%	-16.79%	-14.41%	7.82TCr
REGENERON PHARMACEUTICALS, INC.	-1.69%	+2.50%	-47.97%	-11.41%	5.69TCr
SAMSUNG BIOLOGICS CO.,LTD.	-0.87%	+3.73%	+28.14%	+25.95%	5.35TCr
UCB	+0.82%	+2.67%	+19.96%	+99.33%	3.79TCr
BIOGEN INC.	-2.06%	+3.61%	-42.33%	-40.30%	1.91TCr
INNOVENT BIOLOGICS, INC.	-0.24%	+3.85%	+117.86%	+123.78%	1.8TCr
ALTEOGEN INC.	+11.05%	+12.10%	+49.46%	+690.52%	1.63TCr
INTRA-CELLULAR THERAPIES, INC.	-0.04%	-.--%	+89.58%	+127.32%	1.4TCr
INCYTE CORPORATION	-1.72%	-1.22%	+17.34%	-16.72%	1.3TCr
Average	+0.62%	+2.37%	+22.13%	+109.34%	3.09TCr
Weighted average by Cap.	-0.19%	+3.18%	+5.94%	+57.51%